Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2812-46-6

Post Buying Request

2812-46-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2812-46-6 Usage

Description

H-PRO-OTBU, also known as L-Proline tert-Butyl Ester, is a tert-butyl ester of L-Proline, an amino acid that serves as a precursor for collagen, which is a crucial component in the structure of various connective tissues such as tendons, ligaments, arteries, veins, and muscles. H-PRO-OTBU is characterized by its oily chemical properties and plays a significant role in wound healing.

Uses

Used in Pharmaceutical Industry:
H-PRO-OTBU is used as a pharmaceutical compound for its role in collagen synthesis. Collagen is essential for maintaining the integrity and strength of connective tissues, making H-PRO-OTBU a valuable component in the development of treatments for various conditions affecting the musculoskeletal system.
Used in Cosmetic Industry:
H-PRO-OTBU is used as an ingredient in the cosmetic industry for its potential benefits in promoting skin health and wound healing. Its role in collagen synthesis can contribute to the development of anti-aging products and formulations aimed at improving skin elasticity and reducing the appearance of scars.
Used in Research and Development:
H-PRO-OTBU is utilized as a research compound for studying the mechanisms of collagen synthesis and its role in various biological processes. This can lead to the discovery of new therapeutic approaches and applications in the fields of medicine and biotechnology.
Used in Sports Nutrition:
H-PRO-OTBU is used as a sports nutrition supplement for its potential benefits in enhancing muscle recovery and growth. Its role in collagen synthesis can support the repair and maintenance of muscle tissues, making it a valuable addition to sports supplements and workout recovery products.

Check Digit Verification of cas no

The CAS Registry Mumber 2812-46-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,1 and 2 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2812-46:
(6*2)+(5*8)+(4*1)+(3*2)+(2*4)+(1*6)=76
76 % 10 = 6
So 2812-46-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H17NO2/c1-9(2,3)12-8(11)7-5-4-6-10-7/h7,10H,4-6H2,1-3H3/t7-/m0/s1

2812-46-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H63657)  L-Proline tert-butyl ester, 98%   

  • 2812-46-6

  • 1g

  • 318.0CNY

  • Detail
  • Alfa Aesar

  • (H63657)  L-Proline tert-butyl ester, 98%   

  • 2812-46-6

  • 5g

  • 1274.0CNY

  • Detail

2812-46-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl L-prolinate

1.2 Other means of identification

Product number -
Other names (S)-tert-Butyl pyrrolidine-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2812-46-6 SDS

2812-46-6Relevant articles and documents

Synthesis of the marine sponge cycloheptapeptide phakellistatin 51

Pettit, George R.,Toki, Brian E.,Xu, Jun-Ping,Brune, Daniel C.

, p. 22 - 28 (2000)

Phakellistatin 5 (1), a constituent of The Federated States of Micronesia (Chuuk) marine sponge Phakellia costada, was synthesized by solution-phase and solid-phase techniques. Because the linear peptide bearing (R)-Asn resisted cyclization, the synthesis of this peptide was repeated using the PAL resin attachment proceeding from N-Fmoc-D-Asp-α-OCH2CH=CH2. After addition of the final unit (Ala), the allyl ester was removed under neutral conditions with Pd°[P(C6H5)3l4. Removal of the final Fmoc- protecting group and cyclization with PyAOP provided (R)-Asn-phakellistatin 5 (2) in 28% overall yield. The same synthetic route from (S)-Asp led to natural phakellistatin 5 (1) in 15% overall recovery. The solution-phase and solid-phase synthetic products derived from (S)-Asp were found to be chemically but not biologically identical with natural phakellistatin 5 (1). This important fact suggested that a trace, albeit highly cancer-cell growth inhibitory, constituent accompanied the natural product or that there is a subtle conformational difference between the synthetic and natural cyclic peptides.

Structure, Total Synthesis, and Biosynthesis of Chloromyxamides: Myxobacterial Tetrapeptides Featuring an Uncommon 6-Chloromethyl-5-methoxypipecolic Acid Building Block

Gorges, Jan,Panter, Fabian,Kjaerulff, Louise,Hoffmann, Thomas,Kazmaier, Uli,Müller, Rolf

, p. 14270 - 14275 (2018)

Soil-living microbes are an important resource for the discovery of new natural products featuring great structural diversity that are reflective of the underlying biosynthetic pathways as well as incorporating a wide range of intriguing small-molecule building blocks. We report here the full structural elucidation, total synthesis, and biosynthesis of chloromyxamides, a new class of tetrapeptides that display an unprecedented 6-chloromethyl-5-methoxypipecolic acid (CMPA) substructure. Chemical synthesis—including an approach to access the CMPA unit—was pursued to confirm the structure of the chloromyxamides and enabled determination of the absolute configuration in the CMPA ring. A model for the nonribosomal assembly of chloromyxamides was devised on the basis of the combined evaluation of the biosynthetic gene cluster sequence and the feeding of stable isotope-labeled precursors. This provided insight into the formation of the various chloromyxamide derivatives and the biogenesis of the CMPA unit.

Continuous Flow Synthesis of ACE Inhibitors From N-Substituted l-Alanine Derivatives

Breen, Christopher P.,Jamison, Timothy F.

supporting information, p. 14527 - 14531 (2019/11/03)

A strategy for the continuous flow synthesis of angiotensin converting enzyme (ACE) inhibitors is described. An optimization effort guided by in situ IR analysis resulted in a general amide coupling approach facilitated by N-carboxyanhydride (NCA) activation that was further characterized by reaction kinetics analysis in batch. The three-step continuous process was demonstrated by synthesizing 8 different ACE inhibitors in up to 88 % yield with throughputs in the range of ≈0.5 g h?1, all while avoiding both isolation of reactive intermediates and process intensive reaction conditions. The process was further developed by preparing enalapril, a World Health Organization (WHO) essential medicine, in an industrially relevant flow platform that scaled throughput to ≈1 g h?1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2812-46-6